References
- Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Diabetes Care 2004;27:1047-53
- Stengard JH, Tuomilehto J, Pekkanen J, et al. Diabetes mellitus, impaired glucose tolerance, and mortality among elderly men: the Finnish cohorts of the seven countries study. Diabetologia 1992;35:760-5
- Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child 1998;79:59-62
- IMS Health: IMS Midas (TM) June 2006. Quarterly insulin sales volume in units 2006
- Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
- Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25
- Clarke A, Spollett G. Dose accuracy and injection force dynamics of novel disposable insulin pen. Expert Opin Drug Deliv 2007;4:165-74
- Haenel H, Weise A, Sun W, et al. Differences in the dose accuracy. J Diabetes Sci Technol 2008;2:478-81
- Asakura T, Seino H, Kageyama M, et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin 2008;24:1429-34
- Pfuetzner A, Asakura T, Sommavilla B, et al. Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence. Expert Opin Drug Deliv 2008;5:915-22
- Penfornis A, Horvat K. Dose accuracy comparison between SoloStar and FlexPen at three different dose levels. Diabetes Technol Ther 2008;10:359-62